Epilepsy is the world's most common chronic neurological condition, affecting about 1 in every 100 people. Those who have it ...

Neurelis, Inc., the innovator behind VALTOCO® (diazepam nasal spray), today announced it will join the epilepsy community at the 13th Annual Sofie's Journey Epilepsy Awareness Day & Education Expo at ...

Many medications can cause memory loss, including benzodiazepines, opioids, certain antidepressants, and antihistamines.

Arcutis Biotherapeutics announced strong third-quarter 2025 results, reporting revenue of $99.2 million and achieving profitability for the first time, which surpassed analyst expectations. Following ...

Poking your ear with what looks like a rubber toothbrush, moving your eyes from side to side, tapping your body or gargling ...

The father of a Cuckfield man diagnosed with an incurable brain tumor is taking on a 99-mile challenge. Brain Tumour Research ...

Early seizure onset in DEPDC5-related epilepsy is linked to more severe disease, including drug resistance, intellectual disability, and brain lesions.

Most newly diagnosed patients with epilepsy do gain lasting control of their seizures, even if their first medication doesn’t ...

Rice University bioengineers have demonstrated a nonsurgical way to quiet a seizure-relevant brain circuit in an animal model. The team used low-intensity focused ultrasound to briefly open the ...

Nearly 3.5 million Americans living with epilepsy could benefit from bystander knowledge of proper seizure response.

When she was 3 years old, Alana “Lani” Silverberg was eating a cookie when she started turning blue. Her mom, Sara, thought ...

Veterans who develop epilepsy after traumatic brain injury have higher rates of mortality than those with nontraumatic epilepsy.